Join
Live feed
·
ANALYSTRatingvia Quantisnow
TCR2 Therapeutics Inc. logo

Piper Sandler resumed coverage on TCR2 Therapeutics with a new price target

ByQuantisnow·Wall Street's wire, on your screen.
TCRR· TCR2 Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRR (TCR2 Therapeutics Inc.) and more on Quantisnow.

Piper Sandler resumed coverage on TCR2 Therapeutics with a new price target | Quantisnow